Stem cells: Tissue regeneration and cancer

Seminars in Pediatric Surgery

Volumn 15, Issue 4, 2006, Pages 284-292

  Tataria, Monika ^a   Perryman, Scott V ^a   Sylvester, Karl G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cells; Stem cells; Tissue regeneration

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANTIBODY SPECIFICITY; ARTICLE; CANCER; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; HUMAN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; STEM CELL; TISSUE DIFFERENTIATION; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHILD; EMBRYONIC STEM CELLS; GUIDED TISSUE REGENERATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 33750002878     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2006.07.008     Document Type: Article

References (93)

1. Wobus A.M., and Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85 2 (2005) 635-678
2. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 5819 (1981) 154-156
3. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78 12 (1981) 7634-7638
4. Smith A.G. Embryo-derived stem cells of mice and men. Annu Rev Cell Dev Biol 17 (2001) 435-462
5. Kleinsmith L.J., and Pierce Jr. G.B. Multipotentiality of single embryonal carcinoma cells. Cancer Res 24 (1964) 1544-1551
6. Martin G.R., and Evans M.J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci USA 72 4 (1975) 1441-1445
7. Wilmut I., Schnieke A.E., McWhir J., et al. Viable offspring derived from fetal and adult mammalian cells. Nature 385 6619 (1997) 810-813
8. Bianco P., and Robey P.G. Stem cells in tissue engineering. Nature 414 6859 (2001) 118-121
9. Devine S.M. Mesenchymal stem cells: will they have a role in the clinic?. J Cell Biochem 38 suppl (2002) 73-79
10. Lovell-Badge R. The future for stem cell research. Nature 414 6859 (2001) 88-91
11. Surani M.A. Reprogramming of genome function through epigenetic inheritance. Nature 414 6859 (2001) 122-128
12. McLaren A. Ethical and social considerations of stem cell research. Nature 414 6859 (2001) 129-131
13. Weissman I.L. Stem cells: scientific, medical, and political issues. N Engl J Med 346 20 (2002) 1576-1579
14. Donovan P.J., and Gearhart J. The end of the beginning for pluripotent stem cells. Nature 414 6859 (2001) 92-97
15. Spradling A., Drummond-Barbosa D., and Kai T. Stem cells find their niche. Nature 414 6859 (2001) 98-104
16. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 5391 (1998) 1145-1147
17. Lanza R.P., Chung H.Y., Yoo J.J., et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 20 7 (2002) 689-696
18. Drukker M., Katz G., Urbach A., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99 15 (2002) 9864-9869
19. Rideout III W.M., Hochedlinger K., Kyba M., et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109 1 (2002) 17-27
20. Cibelli J.B., Campbell K.H., Seidel G.E., et al. The health profile of cloned animals. Nat Biotechnol 20 1 (2002) 13-14
21. Humpherys D., Eggan K., Akutsu H., et al. Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci USA 99 20 (2002) 12889-12894
22. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 suppl (2003) 245-254
23. DeBaun M.R., Niemitz E.L., and Feinberg A.P. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alternations of LIT1 and H19. Am J Hum Genet 72 1 (2003) 156-160
24. Maher E.R., Brueton L.A., Bowdin S.C., et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 40 1 (2003) 62-64
25. Reubinoff B.E., Pera M.F., Fong C.Y., et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18 4 (2000) 399-404
26. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99 7 (2002) 4391-4396
27. Murray P., and Edgar D. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). Differentiation 68 4-5 (2001) 227-234
28. Roach M.L., and McNeish J.D. Methods for the isolation and maintenance of murine embryonic stem cells. Methods Mol Biol 185 (2002) 1-16
29. Chambers I., Colby D., Robertson M., et al. : Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 5 (2003) 645-655
30. Loh Y.H., Wu Q., Chew J.L., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38 4 (2006) 431-440
31. Mitsui K., Tokuzawa Y., Itoh H., et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 5 (2003) 631-642
32. Bortvin A., Eggan K., Skaletsky H., et al. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development 130 8 (2003) 1673-1680
33. Lu J., Hou R., Booth C.J., et al. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci USA 103 15 (2006) 5688-5693
34. Lajtha L.G., Gilbert C.W., Porteous D.D., et al. Kinetics of a bone-marrow stem-cell population. Ann N Y Acad Sci 113 (1964) 742-752
35. Fuchs E., Tumbar T., and Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 116 6 (2004) 769-778
36. Osawa M., Hanada K., Hamada H., et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273 5272 (1996) 242-245
37. Watt F.M., and Hogan B.L. Out of Eden: stem cells and their niches. Science 287 5457 (2000) 1427-1430
38. Kondo M., Wagers A.J., Manz M.G., et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21 (2003) 759-806
39. Ponder B.A., Schmidt G.H., Wilkinson M.M., et al. Derivation of mouse intestinal crypts from single progenitor cells. Nature 313 6004 (1985) 689-691
40. Heath J.P. Epithelial cell migration in the intestine. Cell Biol Int 20 2 (1996) 139-146
41. Bianco P., Riminucci M., Gronthos S., et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 3 (2001) 180-192
42. Devine S.M., Peter S., Martin B.J., et al. Mesenchymal stem cells: stealth and suppression. Cancer J 7 suppl 2 (2001) S76-S82
43. Gerson S.L. Mesenchymal stem cells: no longer second class marrow citizens. Nat Med 5 3 (1999) 262-264
44. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
45. Bosch P., Musgrave D.S., Lee J.Y., et al. Osteoprogenitor cells within skeletal muscle. J Orthop Res 18 6 (2000) 933-944
46. Sarugaser R., Lickorish D., Baksh, et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23 2 (2005) 220-229
47. Song L., Young N.J., Webb N.E., et al. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 14 6 (2005) 712-721
48. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13 12 (2002) 4279-4295
49. Michallet M., Thomas X., Vernant J.P., et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant 26 11 (2000) 1157-1163
50. Negrin R.S., Atkinson K., Leemhuis T., et al. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 6 3 (2000) 262-271
51. Vose J.M., Zhang M.J., Rowlings P.A., et al. Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 19 2 (2001) 406-413
52. Shizuru J.A., Negrin R.S., and Weissman I.L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 56 (2005) 509-538
53. Shizuru J.A., Weissman I.L., Kernoff R., et al. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc Natl Acad Sci USA 97 17 (2000) 9555-9560
54. Ballas C.B., Zielske S.P., and Gerson S.L. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem 38 suppl (2002) 20-28
55. Bordignon C., and Roncarolo M.G. Therapeutic applications for hematopoietic stem cell gene transfer. Nat Immunol 3 4 (2002) 318-321
56. Lemoine N.R. The power to deliver: stem cells in gene therapy. Gene Ther 9 10 (2002) 603-605
57. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 5 (2001) 1227-1231
58. Prockop D.J. Targeting gene therapy for osteogenesis imperfecta. N Engl J Med 350 22 (2004) 2302-2304
59. Lagasse E., Shizuru J.A., Uchida, et al. Toward regenerative medicine. Immunity 14 4 (2001) 425-436
60. Park K.I., Ourednik J., Ourednik V., et al. Global gene and cell replacement strategies via stem cells. Gene Ther 9 10 (2002) 613-624
61. Eiselt P., Kim B.S., Chacko B., et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog 14 1 (1998) 134-140
62. Kim W.S., Vacanti C.A., Upton J., et al. Bone defect repair with tissue-engineered cartilage. Plast Reconstr Surg 94 5 (1994) 580-584
63. Ildstad S.T., and Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307 5947 (1984) 168-170
64. Kaufman C.L., and Ildstad S.T. Induction of donor-specific tolerance by transplantation of bone marrow. Ther Immunol 1 2 (1994) 101-111
65. Kleeberger W., Rothanel T., Glockner S., et al. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology 35 1 (2002) 110-116
66. Solter D. From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat Rev Genet 7 4 (2006) 319-327
67. Bosch F.X., Ribes J., Cleries, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 2 (2005) 191-211
68. Billon N., Jolicoeur C., Ying Q.L., et al. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cell Sci 115 Pt 18 (2002) 3657-3665
69. Wu X., Groves F.D., McLaughlin C.C., et al. Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control 16 3 (2005) 309-320
70. Ohtani N., Yamakoshi K., Takahashi A., et al. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51 3-4 (2004) 146-153
71. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 7 (1997) 730-737
72. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 63 18 (2003) 5821-5828
73. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumor initiating cells. Nature 432 7015 (2004) 396-401
74. Cozzio A., Passegue E., Ayton P.M., et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17 24 (2003) 3029-3035
75. Al-Hajj M., Wicha M.S., Benito-Hernandez A., et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100 7 (2003) 3983-3988
76. Hamburger A., and Salmon S.E. Primary bioassay of human myeloma stem cells. J Clin Invest 60 4 (1977) 846-854
77. Hamburger A.W., and Salmon S.E. Primary bioassay of human tumor stem cells. Science 197 4302 (1977) 461-463
78. Southam C.M., Tanzi A.F., and Ross S.L. Growth of primary explants of human cancer in newborn rats. Cancer 19 11 (1966) 1670-1682
79. Berman D.M., Karhadkar S.S., Hallahan A.R., et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297 5586 (2002) 1559-1561
80. de La Coste A., Romagnolo B., Billuart P., et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95 15 (1998) 8847-8851
81. Monga S.P., Pediaditakis P., Mule K., et al. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33 5 (2001) 1098-1109
82. Niemann C., Unden A.B., Lyle S., et al. Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci USA 100 suppl 1 (2003) 11873-11880
83. van de Wetering M., Sancho E., Verweij C., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 2 (2002) 241-250
84. van den Brink G.R., Bleuming S.A., Hardwick J.C., et al. Indian hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 36 3 (2004) 277-282
85. Yau T.O., Chan C.Y., Chan K.L., et al. HDPR1, a novel inhibitor of the WNT/Beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma involvement of methylation-mediated gene silencing. Oncogene 24 9 (2005) 1607-1614
86. Ha N.C., Tonozuka T., Stamos J.L., et al. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15 4 (2004) 511-521
87. Munemitsu S., Albert I., Souza B., et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92 7 (1995) 3046-3050
88. Nhieu J.T., Renard C.A., Wei Y., et al. : Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 155 3 (1999) 703-710
89. Shang X.Z., Zhu H., Lin K., et al. Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest 84 3 (2004) 332-341
90. Terskikh A.V., Easterday M.C., Li L., et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA 98 14 (2001) 7934-7939
91. Obana K., Yang H.W., Piao H.Y., et al. Aberrations of P16INK4A, p14ARF and P15INK4B genes in pediatric solid tumors. Int J Oncol 23 4 (2003) 1151-1157
92. Koesters R., and von Knebel Dueberitz M. The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198 2 (2003) 123-138
93. Buendia M.A. Genetics of hepatocellular carcinoma. Semin Cancer Biol 10 3 (2000) 185-200